Meta-analysis by Jiang et al. observed that the HLA-G 14 bp ins/ins genotype played a protective role in breast cancer patients when compared to the HLA-G 14 bp del/del genotype (with an odds ratio (OR) of 0.65, p < 0.05). This evidence concerns the gene HLA-G and breast cancer.